Generation and phenotypic analysis of sigma receptor type I (σ1) knockout mice

被引:163
作者
Langa, F
Codony, X
Tovar, V
Lavado, A
Giménez, E
Cozar, P
Cantero, M
Dordal, A
Hernández, E
Pérez, R
Monroy, X
Zamanillo, D
Guitart, X
Montoliu, L
机构
[1] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid 28049, Spain
[2] Labs Dr Esteve SA, Res Ctr, Dept Neuropharmacol, Barcelona 08041, Spain
关键词
analgesia; gene targeting; schizophrenia; SKF-10; 047;
D O I
10.1046/j.1460-9568.2003.02950.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Sigma (sigma) sites are a type of nonopiate receptor whose role has been associated with several behaviours, including anxiety, depression, analgesia, learning processes and psychosis. Although there are several known sigma receptor types, only the type I receptor (sigma1) has been cloned. To uncover the in vivo relevance of sigma-receptors, we have generated knockout mice for sigma1. Despite the broad expression pattern found for the sigma1-gene, homozygous mutant mice are viable, fertile and do not display any overt phenotype, compared with their wild-type litter-mates, in mixed genetic backgrounds. However, a significant decrease in the hypermotility response has been measured in knockout mice upon challenge with (+)SKF-10 047, in agreement with the involvement of sigma1-receptors in the induction of psychostimulant actions. The activity of sigma2-receptors seems to be unaffected in sigma1-mutant mice. These knockout mice could contribute to better understand the in vivo role of sigma-receptors.
引用
收藏
页码:2188 / 2196
页数:9
相关论文
共 52 条
[1]  
Ausubel F.A., 1999, CURRENT PROTOCOLS MO
[2]   Putative σ3 sites in mammalian brain have histamine H1 receptor properties:: evidence from ligand binding and distribution studies with the novel H1 radioligand [3 H]-(-)-trans-1-phenyl-3-aminotetralin [J].
Booth, RG ;
Owens, CE ;
Brown, RL ;
Bucholtz, EC ;
Lawler, CP ;
Wyrick, SD .
BRAIN RESEARCH, 1999, 837 (1-2) :95-105
[3]  
Bowen W D, 2000, Pharm Acta Helv, V74, P211
[4]  
BULTMAN S, 1999, GENE TARGETING PRACT, P255
[5]   ACTIVATION OF THE A10 MESOLIMBIC SYSTEM BY THE SIGMA-RECEPTOR AGONIST (+)SKF 10,047 CAN BE BLOCKED BY RIMCAZOLE, A NOVEL PUTATIVE ANTIPSYCHOTIC [J].
CECI, A ;
SMITH, M ;
FRENCH, ED .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 154 (01) :53-57
[6]  
Crawley J. N., 2007, WHATS WRONG MY MOUSE
[7]   CHARACTERIZATION OF THE BINDING OF [H-3] (+)-PENTAZOCINE TO SIGMA-RECOGNITION SITES IN GUINEA-PIG BRAIN [J].
DEHAVENHUDKINS, DL ;
FLEISSNER, LC ;
FORDRICE, FY .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 227 (04) :371-378
[8]   σ2-receptor regulation of dopamine transporter via activation of protein kinase C [J].
Derbez, AE ;
Mody, RM ;
Werling, LL .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (01) :306-314
[9]  
Ganapathy ME, 1999, J PHARMACOL EXP THER, V289, P251
[10]  
GILLIGAN PJ, 1994, DRUG NEWS PERSPECT, V7, P13